These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11032332)

  • 21. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.
    Gillingham MB; Weleber RG; Neuringer M; Connor WE; Mills M; van Calcar S; Ver Hoeve J; Wolff J; Harding CO
    Mol Genet Metab; 2005; 86(1-2):124-33. PubMed ID: 16040264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver and Muscle Contribute Differently to the Plasma Acylcarnitine Pool During Fasting and Exercise in Humans.
    Xu G; Hansen JS; Zhao XJ; Chen S; Hoene M; Wang XL; Clemmesen JO; Secher NH; Häring HU; Pedersen BK; Lehmann R; Weigert C; Plomgaard P
    J Clin Endocrinol Metab; 2016 Dec; 101(12):5044-5052. PubMed ID: 27648961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy - a common feature of the pregnancy complication?
    Eskelin PM; Laitinen KA; Tyni TA
    Mol Genet Metab; 2010 Jun; 100(2):204-6. PubMed ID: 20363656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correcting false positive medium-chain acyl-CoA dehydrogenase deficiency results from newborn screening; synthesis, purification, and standardization of branched-chain C8 acylcarnitines for use in their selective and accurate absolute quantitation by UHPLC-MS/MS.
    Minkler PE; Stoll MSK; Ingalls ST; Hoppel CL
    Mol Genet Metab; 2017 Apr; 120(4):363-369. PubMed ID: 28190699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities between acylcarnitine profiles in large for gestational age newborns and obesity.
    Sánchez-Pintos P; de Castro MJ; Roca I; Rite S; López M; Couce ML
    Sci Rep; 2017 Nov; 7(1):16267. PubMed ID: 29176728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography.
    Minkler PE; Hoppel CL
    Anal Biochem; 1993 Aug; 212(2):510-8. PubMed ID: 8214594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Pons R; Roig M; Riudor E; Ribes A; Briones P; Ortigosa L; Baldellou A; Gil-Gibernau J; Olesti M; Navarro C; Wanders RJ
    Pediatr Neurol; 1996 Apr; 14(3):236-43. PubMed ID: 8736409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS.
    Silva MF; Selhorst J; Overmars H; van Gennip AH; Maya M; Wanders RJ; de Almeida IT; Duran M
    Clin Biochem; 2001 Nov; 34(8):635-8. PubMed ID: 11849623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
    Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
    Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient.
    Moore R; Glasgow JF; Bingham MA; Dodge JA; Pollitt RJ; Olpin SE; Middleton B; Carpenter K
    Eur J Pediatr; 1993 May; 152(5):433-6. PubMed ID: 8319713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection.
    Hua S; Scott JM; Hanna DB; Haberlen SA; Shah SJ; Hodis HN; Landay AL; Lazar JM; Kizer JR; Yu B; Post WS; Anastos K; Kaplan RC; Clish CB; Qi Q
    AIDS; 2019 May; 33(6):1043-1052. PubMed ID: 30946158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
    Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
    Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method.
    Schmidt-Sommerfeld E; Penn D; Duran M; Bennett MJ; Santer R; Stanley CA
    J Pediatr; 1993 May; 122(5 Pt 1):708-14. PubMed ID: 8496747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a new method to identify the G1528C mutation in genomic DNA showing its high frequency (approximately 90%) and identification of a new mutation (T2198C).
    Ijlst L; Ruiter JP; Vreijling J; Wanders RJ
    J Inherit Metab Dis; 1996; 19(2):165-8. PubMed ID: 8739956
    [No Abstract]   [Full Text] [Related]  

  • 40. Anesthesia and bariatric surgery gut preparation alter plasma acylcarnitines reflective of mitochondrial fat and branched-chain amino acid oxidation.
    Bhattacharyya S; Ali M; Smith WH; Minkler PE; Stoll MS; Hoppel CL; Adams SH
    Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E690-E698. PubMed ID: 28830869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.